Abbott has announced the launch and commercial use of its EnSite Precision cardiac mapping system, which allows mapping of abnormal heart rhythms during ablation therapy.
After the approval by the US Food and Drug Administration, the system was commercially used for the first time at Intermountain Heart Institute at Intermountain Medical Center in Salt Lake City by Dr. John Day, an electrophysiologist, during ablation treatment.
Intermountain Heart Rhythm Specialists medical director of Intermountain Medical Center Heart Institute’s Dr. Day said, “The EnSite Precision cardiac mapping system enables clear 3-dimensional images of the heart arrhythmias, which enhances the precision of what is seen during the treatment so that the patient can be treated more accurately.”
Cardiac mapping allows an inner sight of the heart, which makes it easier for the physicians to visualize and then appropriately observe the cardiac anatomy to provide more accurate ablation treatment.
The next-generation system is aimed to provide flexibility, accuracy, and automation in cardiac mapping during the treatment procedures.
Its dual-technology platform provides comprehensive anatomical maps and models to warrant more effective treatment of different irregular heart rhythms including complex arrhythmias such as ventricular tachycardia or atrial fibrillation.
The EnSite Precision cardiac mapping system provides with a solution such as the EnSite AutoMap Module. This module helps the electrophysiologist to rapidly execute morphology matching which can determine the root of the irregular heartbeat. This module is also capable of building a map around 10 times faster using the TurboMap feature.
Isn’t it a great success in the field of surgery? What do you think about this system? Feel free to share your thoughts.